# US 2002/0001830 A1 · Shuttle vectors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0001830 A1
- Document ID: US20020001830A1
- Status: Published application
- Kind: A1
- Application number: 09/208,827
- Filed: 1998-12-09
- Published: 2002-01-03
- Earliest claimed: 1998-08-14
- Assignees: Rigel Pharmaceuticlas, Inc.
- Inventors: YING LUO; PEI WEN YU; JAMES LORENS
- Web page: https://patentgrep.com/patent/US20020001830A1

## CPC

- C12N 15/1082: {Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors}
- C12N 15/1034: {Isolating an individual clone by screening libraries}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/81: for yeasts
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention provides shuttle vectors, and methods of using shuttle vectors, capable of expression in, at least, a mammalian cell. Furthermore, the shuttle vectors are capable of replication in at least yeast, and optionally, bacterial cells. Also provided is a method wherein yeast are transformed with a shuttle vector as provided herein. Heterologous nucleic acids flanked by 5′ and 3′ ends identical to a homologous recombination site within the shuttle vector are introduced to the transformed yeast and allowed to homologously recombine with the shuttle vector such that they are inserted into the vector by the yeast organism. The shuttle vector is then recovered and transferred to a mammalian cell for expression.

## Claims

### Claim 1

A shuttle vector comprising the following components:
an origin of replication functional in yeast;
a selectable gene functional in yeast; and
a promoter functional in a mammalian cell and capable of directing transcription of a polypeptide coding sequence operably linked downstream from said promoter.

### Claim 2 (depends on 1)

The shuttle vector of claim 1 further comprising an insertion site for a heterologous nucleic acid.

### Claim 3 (depends on 2)

The shuttle vector of claim 2 wherein said insertion site is a homologous recombination site.

### Claim 4 (depends on 1)

The shuttle vector of claim 1 further comprising an origin of replication site functional in mammalian cells.

### Claim 5 (depends on 1)

The shuttle vector of claim 1 further comprising an origin of replication functional in a bacterial cell and a selectable gene functional in a bacterial cell.

### Claim 6 (depends on 3)

The shuttle vector of claim 3 further comprising a heterologous nucleic acid inserted within said homologous recombination site.

### Claim 7 (depends on 1)

The shuttle vector of claim 1 further comprising an internal ribosome entry sequence (IRES) positioned between an insertion site and a polyadenylation site.

### Claim 8 (depends on 2)

The shuttle vector of claim 2 further comprising a polyadenylation signal.

### Claim 9 (depends on 2)

The shuttle vector of claim 2 further comprising a splice signal.

### Claim 10

A shuttle vector comprising:
an origin of replication and selectable gene functional in bacteria;
an origin of replication and selectable gene functional in yeast;
a promoter and selectable gene functional in a mammalian cell;
an insertion site operatively linked to said promoter;
a splice signal operatively linked to said promoter downstream from said insertion site;
a polyadenylation signal operatively linked to said promoter downstream from said insertion site; and
an internal ribosome entry sequence (IRES) positioned between said insertion site and said polyadenylation signal.

### Claim 11 (depends on 10)

The vector of claim 10 further comprising long terminal repeats (LTRs) flanking said promoter and said polyadenylation signal.

### Claim 12 (depends on 11)

The vector or claim 11 wherein said LTRs are on a separate strand from a strand comprising said insertion site.

### Claim 13

A method of forming a shuttle vector comprising a heterologous nucleic acid insert for expression in a mammalian cell comprising:
transforming yeast with a shuttle vector comprising an origin of replication functional in yeast, a selectable gene functional in yeast, a promoter functional in a mammalian cell and capable of directing transcription of a polypeptide coding sequence operably linked downstream from said promoter, and a homologous recombination site;
transforming yeast with a vector comprising a heterologous nucleic acid flanked by regions identical to said homologous recombination site;
allowing said shuttle vector to recombine so as to insert said heterologous nucleic acid into said shuttle vector at said homologous recombination site;
isolating said shuttle vector from said yeast;
introducing said shuttle vector to a mammalian cell for expression.
